Abstract
Introduction
Esthesioneuroblastoma (ENB) is an aggressive neuroectodermal malignancy in the upper nasal cavity with local infiltration and lymphatic or hematogenous metastasis. The purpose of this paper is to document three types of direct intracranial extensions by ENB using computed tomography (CT) and magnetic resonance imaging (MRI).
Methods
Eleven patients with pathologically confirmed ENB were admitted in our hospital between December 2002 and December 2008. Their magnetic resonance (MR; n = 10) and CT (n = 8) images were retrospectively reviewed, and particular attention was paid to tumor location and extension, enhancement pattern, cervical lymph node metastasis, and Kadish stage.
Results
The majority of patients were male (8/11) with Kadish stage C tumor (10/11). Three types of direct intracranial extension by ENBs were put forward according to their MR and CT findings. The primary tumors were well-defined soft-tissue masses centered in the roof of the nasal cavity eroding into the paranasal sinuses (11/11), the contralateral nasal cavity (4/11), the cranial cavity (5/11), and the fossa orbitalis (3/11). The tumor parenchyma were hypointensity on T1-weighted images, heterogeneous hyperintensity on T2-weighted images, and isodensity or slight hyperdensity on CT images with scattered necroses (4/11) and marginal cysts(4/11). Their enhancements were significant and inhomogeneous. Cervical lymph nodes metastases were observed in four patients (4/11), but no pathologically proved distant metastasis was observed.
Conclusion
Three types of direct intracranial extensions by ENB can be found on CT and MRI: cranio-orbital-nasal-communicating ENB, cranio-nasal-communicating ENB, and orbital-nasal-communicating ENB.
Similar content being viewed by others
References
Porter AB, Bernold DM, Giannini C et al (2008) Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neuro-oncol 90:201–204
Dulguerov P, Allal AS, Calcaterra TC (2001) Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2:683–690
Lee L, Le QT, **ng L (2008) Retrospective IMRT dose reconstruction based on cone-beam CT and MLC log-file. Int J Radiat Oncol Biol Phys 70:634–644
Bellizzi AM, Bourne TD, Mills SE et al (2008) The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma. Am J Clin Pathol 129:367–376
Bogucki J, Taraszewska A, Czernicki Z (2004) Pure distant, leptomeningeal metastasis of esthesioneuro-epithelioma. Acta Neurochir (Wien) 146:1043–1045
Dahabreh I, Janinis D, Stamatelopoulos AG et al (2007) Surgical resection of esthesioneuroblastoma metastasis to the chest wall. J Thorac Oncol 2:93–95
Sharma S, Lasheen W, Walsh D (2008) Paraneoplastic refractory hypercalcemia due to advanced metastatic esthesioneuroblastoma. Rhinology 46:153–155
Wang XB, Pan XL, Wang TD (2005) Surgical approaches for sinonasal tumors with intracranial extension. Zhonghua Er Bi Yan Hou Tou **g Wai Ke Za Zhi 40:363–365
Wick W, Wick A, Kuker W et al (2004) Intracranial metastatic esthesioneuroblastoma responsive to temozolomide. J Neuro-oncol 70:73–75
Theilgaard SA, Buchwald C, Ingeholm P et al (2003) Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000. Acta Otolaryngol 123:433–439
Berger L, Luc R (1924) L'esthesioneuroepitheliome olfactif. Bull Assoc Fr Etude Cancer 13:410–421
Lee JY, Kim HK (2007) Primary olfactory neuroblastoma originating from the inferior meatus of the nasal cavity. Am J Otolaryngol 28:196–200
Broich G, Pagliari A, Ottaviani F (1997) Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 17:2683–2706
Kleinschmidt-DeMasters BK, Pflaumer SM, Mulgrew TD et al (2000) Sinonasal teratocarcinosarcoma (“mixed olfactory neuroblastoma-craniopharyngioma”) presenting with syndrome of inappropriate secretion of antidiuretic hormone. Clin Neuropathol 19:63–69
Haas I, Ganzer U (2003) Does sophisticated diagnostic workup on neuroectodermal tumors have an impact on the treatment of esthesioneuroblastoma? Onkologie 26:261–267
Hwang SK, Paek SH, Kim DG et al (2002) Olfactory neuroblastomas: survival rate and prognostic factor. J Neuro-oncol 59:217–226
Ingeholm P, Theilgaard SA, Buchwald C et al (2002) Esthesioneuroblastoma: a Danish clinicopathological study of 40 consecutive cases. APMIS 110:639–645
Simon JH, Zhen W, McCulloch TM et al (2001) Esthesioneuroblastoma: the University of Iowa experience 1978–1998. Laryngoscope 111:488–493
Oskouian RJ Jr, Jane JA Sr, Dumont AS et al (2002) Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience. Neurosurg Focus 12:e4
Nguyen BD, Roarke MC, Nelson KD et al (2006) F-18 FDG PET/CT staging and posttherapeutic assessment of esthesioneuroblastoma. Clin Nucl Med 31:172–174
Eriksen JG, Bastholt L, Krogdahl AS et al (2009) Esthesioneuroblastoma—what is the optimal treatment? Acta Oncol 39:231–235
Jethanamest D, Morris LG, Sikora AG et al (2007) Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 133:276–280
Loy AH, Reibel JF, Read PW et al (2006) Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg 132:134–138
Mishima Y, Nagasaki E, Terui Y et al (2004) Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma. Cancer 101:1437–1444
Rosenthal DI, Barker JL Jr, El-Naggar AK et al (2004) Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer 101:2567–2573
Kadish S, Goodman M, Wang CC (1976) Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37:1571–1576
Gondim J, Ramos F Jr, Azevedo J et al (2002) Esthesioneuroblastoma: case report. Arq Neuropsiquiatr 60:303–307
Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK (2004) Principles and Practice of Radiation Oncology, Lippincott Williams & Wilkins, 4th edn. (September 1, 2003), pp. 1132–3911
Diaz EM Jr, Johnigan RH 3rd, Pero C et al (2005) Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck 27:138–149
Zafereo ME, Fakhri S, Prayson R et al (2008) Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg 138:452–458
Devaiah AK, Larsen C, Tawfik O et al (2003) Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection. Laryngoscope 113:2086–2090
Castelnuovo PG, Delu G, Sberze F et al (2006) Esthesioneuroblastoma: endonasal endoscopic treatment. Skull Base 16:25–30
Bradley PJ, Jones NS, Robertson I (2003) Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg 11:112–118
Resto VA, Eisele DW, Forastiere A et al (2000) Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 22:550–558
Sheehan JM, Sheehan JP, Jane JA Sr et al (2000) Chemotherapy for esthesioneuroblastomas. Neurosurg Clin N Am 11:693–701
Dias FL, Sa GM, Lima RA et al (2003) Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg 129:1186–1192
Constantinidis J, Steinhart H, Koch M et al (2004) Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975–2000. Otolaryngol Head Neck Surg 130:567–574
Rinaldo A, Ferlito A, Shaha AR et al (2002) Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Otolaryngol 122:215–221
Lund VJ, Howard D, Wei W et al (2003) Olfactory neuroblastoma: past, present, and future? Laryngoscope 113:502–507
Liao H, Hua QQ, Wu ZY (2006) Maxillary swing approach in the management of tumors in the central and lateral cranial base. Zhonghua Er Bi Yan Hou Tou **g Wai Ke Za Zhi 41:276–280
Josephs L, Jones L, Marenette L et al (2008) Cushing's syndrome: an unusual presentation of olfactory neuroblastoma. Skull Base 18:73–76
Yu J, Koch CA, Patsalides A et al (2004) Ectopic Cushing's syndrome caused by an esthesioneuroblastoma. Endocr Pract 10:119–124
Miura K, Mineta H, Yokota N et al (2001) Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy. Pathol Int 51:942–947
Chacko G, Chandi SM, Chandy MJ (1998) Primary sphenoid and petrous apex esthesioneuroblastoma: a case report. Br J Neurosurg 12:264–266
Sarwar M (1979) Primary sellar–parasellar esthesioneuroblastoma. Am J Roentgenol 133:140–141
Mashberg A, Thoma KH, Wasilewski EJ (1979) Olfactory neuroblastoma (esthesioneuroblastoma) of the maxillary sinus. Oral Surg 13:908–912
Castro L, De La Pava S, Webster JH (1969) Esthesioneuroblastomas: a report of 7 cases. Am J Roentgenol Radium Ther Nucl Med 105:7–13
Levine PA, Gallagher R, Cantrell RW (1999) Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 109:1539–1543
Som PM, Lidov M, Brandwein M et al (1994) Sinonasal esthesioneuroblastoma with intracranial extension: marginal tumor cysts as a diagnostic MR finding. AJNR Am J Neuroradiol 15:1259–1262
Manelfe C, Bonafe A, Fabre P et al (1978) Computed tomography in olfactory neuroblastoma: one case of esthesioneuroepithelioma and four cases of esthesioneuroblastoma. J Comput Assist Tomogr 2:412–420
Yuan Y, Peng S, **e Z (1999) Evaluation of CT in the diagnosis of esthesioneuroblastoma. Zhonghua Zhong Liu Za Zhi 21:134–135
Acknowledgement
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, T., Xu, YK., Li, L. et al. Esthesioneuroblastoma methods of intracranial extension: CT and MR imaging findings. Neuroradiology 51, 841–850 (2009). https://doi.org/10.1007/s00234-009-0581-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-009-0581-0